NAICS 325414

What is the NAICS code 325414?

The NAICS code 325414 is applied to those industries related to Biological Product (except Diagnostic) Manufacturing.

This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

Therefore, all companies engaged in any industrial activity related to this type of business are grouped under category 325414 in the North American Industry Classification System.

This industrial activity of NAICS code is structured as follows:

• 32 - Manufacturing
• 325 - Chemical Manufacturing
• 3254 - Pharmaceutical and Medicine Manufacturing
• 32541 - Pharmaceutical and Medicine Manufacturing
• 325414 - Biological Product (except Diagnostic) Manufacturing

Characteristics of the North American Industry Classification System code 325414

NAFTA

This code is only used in the North American Industry Classification System (NAICS). It´s to say, it is not used in the North American Free Trade Agreement (NAFTA): United States, Canada, and Mexico.

Related codes

The NAICS industry 325414 has the following cross-references:

• Manufacturing in-vitro diagnostic substances are classified in U.S. Industry 325413, In-Vitro Diagnostic Substance Manufacturing.
• Manufacturing pharmaceutical preparations (except biological and in-vitro diagnostic substances) are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.

Related activities

Below are some of the most common types of activities in the Biological Product (NAICS Code except Diagnostic) Manufacturing industry (NAICS Code 325414):

• Agar culture media manufacturing
• Aggressins (except in-vitro) manufacturing
• Allergenic extracts (except diagnostic substances) manufacturing
• Allergens manufacturing
• Antigens manufacturing
• Antiserums manufacturing
• Antitoxins manufacturing
• Antivenoms manufacturing
• Bacterial vaccines manufacturing
• Bacterins (i.e., bacterial vaccines) manufacturing
• Blood derivatives manufacturing
• Blood fractions manufacturing
• Cholera serums manufacturing
• Culture media manufacturing
• Gene therapy preparations manufacturing
• Hematology products (except diagnostic substances) manufacturing
• Plasmas manufacturing
• Serums (except diagnostic substances) manufacturing
• Toxoids (e.g., diphtheria, tetanus) manufacturing
• Tuberculin (i.e., tuberculo-protein derived) manufacturing
• Vaccines (i.e., bacterial, virus) manufacturing
• Virus vaccines manufacturing